ZS, a global provider of life sciences consulting and technology solutions has inked a partnership with digital health-focused venture fund Rock Health to bring the latest innovations to its life sciences expertise. Rock Health’s partners span the healthcare spectrum, from leading health systems to payers, manufacturers and industry advocates, all focused on removing barriers and supporting industry growth. This partnership enables ZS to bring its thought leadership and deep technical expertise to help shape policy and advocacy around digital health industry issues, from payment models to provider participation, to data sharing and ecosystem collaboration.
Digital health investments and innovations continue to grow at an ever-increasing pace, making digital health among the key disruptive forces that will shape the future of healthcare. ZS believes that this evolution is a significant trend that will impact how the pharma and medical products sectors will create new value, pursue new business models and realize significant gains in their operating models, from R&D to commercial
“This partnership brings together a compelling mix of complementary strengths from both organizations,” said Pete Masloski, a managing principal at ZS and leader of the firm’s global digital and connected health practice. “ZS has deep expertise in helping pharmaceutical and medtech companies successfully commercialize and bring to market new products and services. Combined with Rock Health’s deep expertise in innovation and digital health, our partnership will help both digital health innovators and pharma and medtech companies be more successful with their digital health efforts.”
“We’re well suited to working together, both with Rock Health and their partners, because we share the focus on impact—on improving healthcare treatment and delivery, and, ultimately, patient outcomes,” Masloski said. “And both firms are dedicated to working with healthcare players on the ground to develop and implement new strategies and innovations. We’re active participants in healthcare’s evolution. It’s in our DNA.”
